DI CHIO, Carla
 Distribuzione geografica
Continente #
EU - Europa 437
NA - Nord America 322
AS - Asia 72
AF - Africa 4
Totale 835
Nazione #
US - Stati Uniti d'America 322
IT - Italia 139
IE - Irlanda 126
SE - Svezia 68
AT - Austria 57
SG - Singapore 40
PL - Polonia 30
CN - Cina 21
IN - India 5
FI - Finlandia 4
FR - Francia 4
NG - Nigeria 4
DE - Germania 3
UA - Ucraina 3
KW - Kuwait 2
NL - Olanda 2
VN - Vietnam 2
AM - Armenia 1
ID - Indonesia 1
LV - Lettonia 1
Totale 835
Città #
Dublin 126
Chandler 119
Nyköping 65
Vienna 57
Messina 36
Singapore 32
Warsaw 30
Ashburn 25
Princeton 18
Medford 15
Aversa 12
Des Moines 12
Beijing 8
Siderno 7
Francavilla di Sicilia 6
Rome 5
Santa Clara 5
Cagliari 4
New Delhi 4
Catania 3
Groß-umstadt 3
Irpin 3
Lentini 3
Leonforte 3
Nocera Terinese 3
Amsterdam 2
Bari 2
Caltagirone 2
Dong Ket 2
Dongguan 2
Ferrara 2
Hebei 2
Helsinki 2
Jinan 2
Katsina 2
Kuwait City 2
Lagos 2
Milan 2
Palermo 2
Riposto 2
Shenyang 2
Turin 2
Boardman 1
Boston 1
Gravina di Catania 1
Haikou 1
Houston 1
Hyderabad 1
Jacksonville 1
Jakarta 1
Jiaxing 1
Lappeenranta 1
Los Angeles 1
Ningbo 1
Piazza Armerina 1
Redmond 1
Riesi 1
Riga 1
Rosarno 1
Schignano 1
Scordia 1
Seattle 1
Taizhou 1
Trecastagni 1
Wilmington 1
Yerevan 1
Zhengzhou 1
Totale 663
Nome #
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 88
Design, synthesis and biological evaluation of novel bioactive molecules for the treatment of protozoan and human diseases 71
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 58
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 56
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 55
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 48
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 47
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 47
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 43
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 35
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 31
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 31
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 30
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 29
null 27
Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents 25
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 24
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 21
null 21
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 21
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 17
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 17
Monoclonal antibodies: the greatest resource to treat multiple myeloma 16
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 16
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 13
null 11
null 9
Dihydrochalcones as antitumor agents. 7
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 6
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 5
KCNT1 Channel Blockers: A Medicinal Chemistry Perspective 4
Synthesis and cytotoxicity of diarylpentanoids against sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells 2
Totale 931
Categoria #
all - tutte 4.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 1 6 0 2 11 7 9
2020/202171 2 4 9 3 11 14 7 2 8 7 2 2
2021/2022116 5 2 1 9 9 4 3 2 8 3 12 58
2022/2023472 19 54 20 45 35 50 18 36 143 5 41 6
2023/2024152 34 17 6 31 10 2 1 5 4 12 24 6
2024/202584 11 5 13 43 12 0 0 0 0 0 0 0
Totale 931